论文部分内容阅读
上海“十一五”规划将生物医药产业作为支撑上海未来经济发展的战略产业之一,发展目标:到2010年,争取实现20个创新药物的产业化,30个创新药物进行临床研究;涌现出15～20家年收入超过10亿元的科技企业,形成2～3家年收入超过百亿元的“旗舰”企业;全市生物医药产业年销售收入达到
The 11th Five-Year Plan of Shanghai regards the biomedical industry as one of the strategic industries that support the economic development of Shanghai in the future. Its goal is to strive for the industrialization of 20 innovative drugs and 30 innovative drugs for clinical research by 2010. 15 to 20 science and technology enterprises with an annual revenue of more than 1 billion yuan will form 2 to 3 “flagship” enterprises with annual revenues exceeding 10 billion yuan; the annual sales revenue of the city’s biomedicine industry will reach